Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Equity Average (2016 - 2025)

Orthofix Medical's Equity Average history spans 15 years, with the latest figure at $446.3 million for Q4 2025.

  • For the quarter ending Q4 2025, Equity Average fell 13.27% year-over-year to $446.3 million, compared with a TTM value of $446.3 million through Dec 2025, down 13.27%, and an annual FY2025 reading of $476.6 million, down 13.49% over the prior year.
  • Equity Average for Q4 2025 was $446.3 million at Orthofix Medical, down from $450.4 million in the prior quarter.
  • The five-year high for Equity Average was $652.1 million in Q2 2023, with the low at $335.2 million in Q4 2022.
  • Average Equity Average over 5 years is $459.7 million, with a median of $454.4 million recorded in 2025.
  • Year-over-year, Equity Average skyrocketed 92.49% in 2023 and then fell 17.89% in 2025.
  • Tracing OFIX's Equity Average over 5 years: stood at $350.9 million in 2021, then decreased by 4.47% to $335.2 million in 2022, then soared by 81.12% to $607.1 million in 2023, then decreased by 15.25% to $514.5 million in 2024, then fell by 13.27% to $446.3 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Equity Average are $446.3 million (Q4 2025), $450.4 million (Q3 2025), and $458.3 million (Q2 2025).